Guardant Health’s precision oncology tests - Guardant Reveal
TM
, Guardant360® CDx, and Guardant360 TissueNext
TM
are now available from Codex Genetics.
Bioinformatics
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Pan-Cancer Marker Test
Congenital Cardiovascular Disease
Metagenomics
Retinitis Pigmentosa
Professionals
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
Sign up
Sign In
Bioinformatics
Products & Services
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Pan-Cancer Marker Test
Congenital Cardiovascular Disease
Metagenomics
Retinitis Pigmentosa
Professionals
About Us
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
Sign Up
Login
Cancer Therapy
Somatic Mutation and Germline Mutation in Cancer
Date：2022-03-02
Why should breast cancer patients confirm PIK3CA mutation?
Date：2021-12-14
Companion Diagnostics: integration of Diagnostic Testing into Treatment Pathway
Date：2021-12-13
Early Detection of BRCA Gene Mutations and Tackle the Refractory Triple-Negative Breast Cancer
Date：2020-10-07
RNA-based NGS – the best way to identify NTRK gene fusion
Date：2020-09-02
NTRK Gene Fusion: A Burgeoning Marker for Pan-Cancer Targeted Therapy
Date：2020-09-02
We use cookies to ensure that you have the best experience on our website. If you continue to use this site we assume that you accept this.
OK
